Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nonmyeloablative second transplants are associated with lower nonrelapse mortality and superior survival than myeloablative second transplants.
Hill BT, Bolwell BJ, Rybicki L, Dean R, Kalaycio M, Pohlman B, Tench S, Sobecks R, Andresen S, Copelan E. Hill BT, et al. Among authors: andresen s. Biol Blood Marrow Transplant. 2010 Dec;16(12):1738-46. doi: 10.1016/j.bbmt.2010.06.009. Epub 2010 Jun 14. Biol Blood Marrow Transplant. 2010. PMID: 20558313 Free article.
Risk factors for 30-day hospital readmission following myeloablative allogeneic hematopoietic cell transplantation (allo-HCT).
Bejanyan N, Bolwell BJ, Lazaryan A, Rybicki L, Tench S, Duong H, Andresen S, Sobecks R, Dean R, Pohlman B, Kalaycio M, Copelan EA. Bejanyan N, et al. Among authors: andresen s. Biol Blood Marrow Transplant. 2012 Jun;18(6):874-80. doi: 10.1016/j.bbmt.2011.10.032. Epub 2011 Oct 29. Biol Blood Marrow Transplant. 2012. PMID: 22040844 Free article.
Long-term survival after high-dose chemotherapy with autologous hematopoietic cell transplantation in metastatic breast cancer.
Hamilton BK, Rybicki L, Abounader D, Andresen S, Kalaycio M, Sobecks R, Pohlman B, Hanna R, Dean R, Liu H, Hill B, Bolwell B, Copelan E. Hamilton BK, et al. Among authors: andresen s. Hematol Oncol Stem Cell Ther. 2015 Sep;8(3):115-24. doi: 10.1016/j.hemonc.2015.06.005. Epub 2015 Jul 7. Hematol Oncol Stem Cell Ther. 2015. PMID: 26183670 Free article.
Daily Weight-Based Busulfan with Cyclophosphamide and Etoposide Produces Comparable Outcomes to Four-Times-Daily Busulfan Dosing for Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.
Hill BT, Rybicki L, Carlstrom KD, Jagadeesh D, Gerds A, Hamilton B, Liu H, Dean R, Sobecks R, Pohlman B, Andresen S, Kalaycio M, Bolwell BJ, Majhail NS. Hill BT, et al. Among authors: andresen s. Biol Blood Marrow Transplant. 2016 Sep;22(9):1588-1595. doi: 10.1016/j.bbmt.2016.06.011. Epub 2016 Jun 22. Biol Blood Marrow Transplant. 2016. PMID: 27343718 Free article.
Comparative Effectiveness of Busulfan and Fludarabine versus Fludarabine and 400 cGy Total Body Irradiation Conditioning Regimens for Acute Myeloid Leukemia/Myelodysplastic Syndrome.
Mustafa Ali M, Abounader DM, Rybicki LA, Yurch MA, Starn J, Ferraro C, Winslow V, Hamilton BK, Gerds AT, Liu H, Dean R, Hill BT, Pohlman B, Andresen S, Hanna R, Kalaycio M, Bolwell BJ, Majhail NS, Sobecks RM. Mustafa Ali M, et al. Among authors: andresen s. Biol Blood Marrow Transplant. 2017 May;23(5):776-781. doi: 10.1016/j.bbmt.2017.01.077. Epub 2017 Jan 17. Biol Blood Marrow Transplant. 2017. PMID: 28108271 Free article.
Efficacy of Standard Dose R-CHOP Alternating With R-HDAC Followed by Autologous Hematopoietic Cell Transplantation as Initial Therapy of Mantle Cell Lymphoma, a Single-Institution Experience.
Sawalha Y, Hill BT, Rybicki LA, Sun D, Dean RM, Jagadeesh D, Hamilton BK, Gerds AT, Sobecks RM, Andresen S, Liu HK, Majhail NS, Pohlman B, Kalaycio ME, Bolwell BJ, Smith MR. Sawalha Y, et al. Among authors: andresen s. Clin Lymphoma Myeloma Leuk. 2018 Jan;18(1):e95-e102. doi: 10.1016/j.clml.2017.11.002. Epub 2017 Dec 6. Clin Lymphoma Myeloma Leuk. 2018. PMID: 29208403
Long-term outcome of Hodgkin disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantation.
Wadehra N, Farag S, Bolwell B, Elder P, Penza S, Kalaycio M, Avalos B, Pohlman B, Marcucci G, Sobecks R, Lin T, Andrèsen S, Copelan E. Wadehra N, et al. Among authors: andresen s. Biol Blood Marrow Transplant. 2006 Dec;12(12):1343-9. doi: 10.1016/j.bbmt.2006.08.039. Biol Blood Marrow Transplant. 2006. PMID: 17162217 Free article.
Superior survival after replacing oral with intravenous busulfan in autologous stem cell transplantation for non-Hodgkin lymphoma with busulfan, cyclophosphamide and etoposide.
Dean RM, Pohlman B, Sweetenham JW, Sobecks RM, Kalaycio ME, Smith SD, Copelan EA, Andresen S, Rybicki LA, Curtis J, Bolwell BJ. Dean RM, et al. Among authors: andresen s. Br J Haematol. 2010 Jan;148(2):226-34. doi: 10.1111/j.1365-2141.2009.07940.x. Epub 2009 Oct 11. Br J Haematol. 2010. PMID: 19821828 Free article.
160 results